Stanford University
Showing 5,251-5,260 of 7,811 Results
-
Grant Parker
Associate Professor of Classics, of African and African American Studies and, by courtesy, of Comparative Literature
BioGrant Parker joined Stanford from Duke University in 2006. He teaches Latin and other topics in Roman imperial culture; he has worked on the history of collecting and on historical maps. His books include The Making of Roman India (2008) and The Agony of Asar: a former slave's defence of slavery, 1742 (2001). He has edited a major volume, South Africa, Greece, Rome: classical confrontations (forthcoming 2016/7). Current research projects focus on memorialization and public history, in both Rome and South Africa (including comparison).
-
Karen J. Parker, PhD
Truong-Tan Broadcom Endowed Professor and Professor, by courtesy, of Comparative Medicine
Current Research and Scholarly InterestsThe Parker Lab conducts research on the biology of social functioning in monkeys, typically developing humans, and patients with social difficulties.
-
Patricia Parker
Margery Bailey Professor of English and Dramatic Literature and Professor of Comparative Literature
BioPatricia Parker received her M.A. in English at the University of Toronto and taught for three years in Tanzania, whose President Julius Nyerere also translated Shakespeare into Kiswahili. After teaching at the University of East Africa, she completed her Ph.D. at Yale, in Comparative Literature, and taught for 11 years at the University of Toronto. First invited to Stanford as a Visiting Professor in 1986, she came to Stanford permanently in 1988 as a Professor in both English and Comparative Literature. She has also taught as a Visiting Professor at UC Berkeley and as a member of the core faculty at the School of Criticism and Theory (Cornell University, 1998). She is the author of four books (Inescapable Romance, a study of romance from Ariosto to Wallace Stevens; Literary Fat Ladies: Rhetoric, Gender, Property; Shakespeare from the Margins; and Shakespearean Intersections) and co-editor of five collections of essays on criticism, theory, and cultural studies, including Shakespeare and the Question of Theory and Women, Race and Writing in the Early Modern Period. She has lectured widely in France, Germany, Spain, Australia, New Zealand, the Czech Republic, and other parts of the world, as well as at Harvard, Yale, Berkeley, Chicago, Oxford, Cambridge, the Sorbonne, and other universities; as Gauss Seminar lecturer at Princeton, Shakespeare's Birthday lecturer at the Folger Shakespeare Library, Northrop Frye Professor lecturer at the University of Toronto, and Paul Gottschalk lecturer at Cornell University; and has served on the Advisory Board of the English Institute. In 2003-4, she organized an international conference and public festival at Stanford devoted to “Shakespeare in Asia.” She has also worked with students to create performance-based programs in the community. She currently teaches courses on Shakespeare (including Global Shakespeares), the Bible and Literature, Epic and Empire and other topics. In addition to books-in-progress on Shakespeare, rhetoric, race, and gender, she is the General Editor of the Stanford Global Shakespeare Encyclopedia, which will be released online as a global reference work free to anyone in the world with access to the internet.
-
Bradford Parkinson
Edward C. Wells Professor in the School of Engineering, Emeritus
BioProfessor Bradford Parkinson was the Chief Architect for GPS, and led the original advocacy for the system in 1973 as an Air Force Colonel. Gaining approval, he became the first Director of the GPS Joint Program Office and led the original development of spacecraft, Master Control Station and 8 types of User Equipment. He continued leadership of the Program through the extensive test validation Program, including being the Launch Commander for the first GPS satellite launches. This original deployment of GPS demonstrated comfortable margins against all PNT (Positioning, Navigation, and Timing) requirements.
Earlier in his career, he was a key developer of a modernized AC-130 Gunship, introduction of which included 160 hours of combat missions. He was an instructor at the USAF Test Pilot School. In addition he led the Department of Astronautics and Computer Science at the US Air Force Academy. He retired from the US Air Force as a Colonel.
He was appointed a Professor at Stanford University in 1984, after six years of experience in industry. At Stanford University, he led the development of many innovative applications of GPS, including:
1.Commercial aircraft (Boeing 737) blind landing using GPS alone,
2.Fully automatic GPS control of Farm Tractors on a rough field to an accuracy of 2 inches,
3.Pioneering the augmentation to GPS (WAAS) that allows any user to achieve accuracies of 2 feet and very high levels of integrity assurance.
He has been the CEO of two companies, and serves on many boards. He is the editor/author of the AIAA Award winning 2 Volumes: “GPS Theory and Applications” and is author or coauthor of over 80 technical papers.
Among his many awards is the Draper Prize of the National Academy of Engineering, considered by some to be the “Engineering Nobel”. -
Robertson Parkman
Other Teaching Staff-Hourly, Pediatrics - Stem Cell Transplantation
BioMy principal research interests have been the assessment of the immunological consequences of hematopoietic stem cell transplantation including both acute and chronic graft versus host disease and immune reconstitution and the use of hematopoietic stem cell transplantation to treat genetic diseases. My laboratory was the first to suggest that chronic graft versus host disease was an autoimmune disease directed at histocompatibility antigens shared by donors and recipients. The observation leaded to the assessment of the role of thymic dysfunction in the pathogenesis of chronic graft versus host disease. As a pediatric immunologist I have investigated the role of hematopoietic stem cell transplantation initially in the treatment of primary immune deficiency diseases and later the treatment of metabolic diseases, which lead to my involvement in the early gene transfer clinical trials.
